Aspirin may not provide benefits for type 2 diabetes patients

04/29/2013 | DailyRx.com

Type 2 diabetes patients with no previous cardiovascular disease who were on low-dose aspirin treatment did not show a lower risk of cardiovascular disease or death at 3.9 years compared with nonusers, according to a study in BMJ Open. Researchers noted a slightly increased risk of both fatal and non-fatal heart disease in female aspirin users compared with women who did not take the drug.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT